| Age, mean (SD), years |
48.6(13.3) |
| Gender, female, n (%) |
221 (83.1) |
| Ethnicity, n (%) |
|
|
Caucasian
|
125 (46.9) |
|
Hispanic
|
77 (28.9) |
|
African-American
|
54 (20.3) |
|
Other
|
10 (3.9) |
| Disease duration, mean (SD), years |
2.5 (1.6) |
| Cutaneous involvement, diffuse, n (%) |
156 (58.6) |
| Autoantibody profile, n (%) |
|
|
Anti-centromere antibody
|
32 (12.0) |
|
Anti-topoisomerase antibody
|
49 (18.4) |
|
Anti-polymerase III antibody
|
62 (23.3) |
|
Anti-ribonucleic protein antibody
|
30 (11.3) |
| Modified Rodnan Skin Score (MRSS), mean (SD) |
15.8 (11.8) |
| Fatigue Severity Scale (FSS) score, mean (SD) |
4.7 (0.9) |
| Interpersonal Support Evaluation List (ISEL) score, mean (SD) |
8.1 (1.6) |
